Have a feature idea you'd love to see implemented?
Let us know!
AVNS Avanos Medical Inc
Price (delayed)
$15.83
Market cap
$727.5M
P/E Ratio
45.23
Dividend/share
N/A
EPS
$0.35
Enterprise value
$840.7M
Avanos Medical, Inc. is a medical technology company focused on delivering clinical medical device solutions. The company consists of two franchises – Pain Management and Chronic Care – that address
Highlights
The EPS has soared by 130% YoY and by 106% from the previous quarter
The net income has soared by 128% YoY and by 104% from the previous quarter
The quick ratio has declined by 30% year-on-year
The gross profit has contracted by 2.4% YoY
Key stats
What are the main financial stats of AVNS
Market
Valuations
Earnings
Shares outstanding
45.96M
Market cap
$727.5M
Enterprise value
$840.7M
Price to earnings (P/E)
45.23
Price to book (P/B)
0.59
Price to sales (P/S)
1.07
EV/EBIT
25.63
EV/EBITDA
10.68
EV/Sales
1.23
Revenue
$681.5M
Gross profit
$378.3M
Net income
$15.7M
EBIT
$32.8M
EBITDA
$78.7M
Free cash flow
$36.6M
Per share
Balance sheet
Liquidity
EPS
$0.35
EPS diluted
$0.34
Free cash flow per share
$0.8
Book value per share
$26.76
Revenue per share
$14.83
TBVPS
$13.95
Total assets
$1.66B
Total liabilities
$426.5M
Debt
$202.2M
Equity
$1.23B
Working capital
$259.7M
Debt to equity
0.16
Current ratio
2.22
Quick ratio
1.04
Net debt/EBITDA
1.44
Margins
Efficiency
Dividend
EBITDA margin
11.5%
Gross margin
55.5%
Net margin
2.3%
Operating margin
5.5%
Return on assets
0.9%
Return on equity
1.3%
Return on invested capital
5.9%
Return on capital employed
2.3%
Return on sales
4.8%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
AVNS stock price
How has the Avanos Medical stock price performed over time
Intraday
0.19%
1 week
2.39%
1 month
-11.91%
1 year
-18.82%
YTD
-0.57%
QTD
-0.57%
Financial performance
How have Avanos Medical's revenue and profit performed over time
Revenue
$681.5M
Gross profit
$378.3M
Operating income
$37.7M
Net income
$15.7M
Gross margin
55.5%
Net margin
2.3%
The net income has soared by 128% YoY and by 104% from the previous quarter
Avanos Medical's net margin has soared by 128% YoY and by 109% from the previous quarter
The operating income has soared by 81% YoY
Avanos Medical's operating margin has soared by 77% YoY
Growth
What is Avanos Medical's growth rate over time
Valuation
What is Avanos Medical stock price valuation
P/E
45.23
P/B
0.59
P/S
1.07
EV/EBIT
25.63
EV/EBITDA
10.68
EV/Sales
1.23
The EPS has soared by 130% YoY and by 106% from the previous quarter
AVNS's price to book (P/B) is 46% less than its 5-year quarterly average of 1.1 and 26% less than its last 4 quarters average of 0.8
The P/S is 47% lower than the 5-year quarterly average of 2.0 and 29% lower than the last 4 quarters average of 1.5
Efficiency
How efficient is Avanos Medical business performance
The ROE has soared by 130% YoY and by 117% from the previous quarter
The return on assets has surged by 128% year-on-year and by 80% since the previous quarter
AVNS's ROIC is up by 23% from the previous quarter
The ROS has grown by 14% from the previous quarter
Dividends
What is AVNS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for AVNS.
Financial health
How did Avanos Medical financials performed over time
The quick ratio has declined by 30% year-on-year
The company's current ratio fell by 28% YoY and by 2.6% QoQ
Avanos Medical's debt is 84% less than its equity
The debt to equity has contracted by 36% YoY and by 11% from the previous quarter
Avanos Medical's debt has decreased by 34% YoY and by 7% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.